References
- AbramsonDHShieldsCLMunierFLChantadaGLTreatment of retinoblastoma in 2015 agreement and disagreementJAMA Ophthalmol2015133111341134726378747
- MurphreeALVillablancaJGDeeganWF3rdChemotherapy plus local treatment in the management of intraocular retinoblastomaArch Ophthalmol199611411134813568906025
- ShieldsCLShieldsJANeedleMCombined chemoreduction and adjuvant treatment for intraocular retinoblastomaOphthalmology199710412210121119400771
- DunkelIJLeeTCShiWA phase II trial of carboplatin for intraocular retinoblastomaPediatr Blood Cancer200749564364817301956
- DraperGJSandersBMKingstonJESecond primary neoplasms in patients with retinoblastomaBr J Cancer19865356616713718823
- AbramsonDHScheflerACUpdate on retinoblastomaRetina200424682884815579980
- RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
- LaurieNAGrayNKZhangJTopotecan combination chemotherapy in two new rodent models of retinoblastomaClin Cancer Res200511207569757816243833
- StewartCFZamboniWCCromWRTopoisomerase I interactive drugs in children with cancerInvest New Drugs199614137478880392
- ZamboniWCStewartCFThompsonJRelationship between topotecan systemic exposure and tumor response in human neuroblastoma xenograftsJ Natl Cancer Inst19989075055119539245
- BuitragoEHöchtCChantadaGPharmacokinetic analysis of topotecan after intra-vitreal injection implications for retinoblastoma treatmentExp Eye Res201091191420307538
- LuJLiongMZinkJITamanoiFMesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugsSmall2007381341134617566138
- ChoiJYRamasamyTKimSYPEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapyActa Biomater2016399410527163403
- RamasamyTRuttalaHBChoiJYEngineering of a lipid-polymer nanoarchitectural platform for highly effective combination therapy of doxorubicin and irinotecanChem Commun20155157585761
- LiongMLuJKovochichMMultifunctional inorganic nanoparticles for imaging, targeting, and drug deliveryACS Nano20082588989619206485
- LuJLiongMLiZZinkJITamanoiFBiocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animalsSmall20106161794180520623530
- HomCLuJLiongMMesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cellsSmall20106111185119020461725
- CraneLMArtsHJvan OostenMThe effect of chemotherapy on expression of folate receptor-alpha in ovarian cancerCell Oncol (Dordr)201235191821647742
- RamasamyTRuttalaHBGuptaBSmart chemistry-based nano-sized drug delivery systems for systemic applications: a comprehensive reviewJ Control Release201725822625328472638
- LeamonCPReddyJAFolate-targeted chemotherapyAdv Drug Deliv Rev20045681127114115094211
- LuYLowPSImmunotherapy of folate receptor-expressing tumors: review of recent advances and future prospectsJ Control Release2003911–2172912932634
- KansaraVPaturiDLuoSGaudanaRMitraAKFolic acid transport via high affinity carrier-mediated system in human retinoblastoma cellsInt J Pharm20083551–221021918207340
- PanJFengSSTargeted delivery of paclitaxel using folate-decorated poly(lactide)-vitamin E TPGS nanoparticlesBiomaterials200829172663267218396333
- TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077